Â
Description:
Featuring more than 4100 references, Drug-Induced Liver Disease is an invaluable reference for gastroenterologists, hepatologists, family physicians, internists, pathologists, pharmacists, pharmacologists, and clinical toxicologists, and graduate and medical school students in these disciplines. This book supplies an in-depth discussion of drug-ind
Â
Â
Table of Contents:
Â
PART I: MECHANISMS OF LIVER INJURY
Chapter
1. Drug-Induced Liver Disease
Chapter
2. Cytochrome P450 Activation of Toxins and Hepatoxicity
Chapter
3. Antioxidant Defense in Liver Injury: Oxidant Stress, Antioxidant Defense, and Liver Injur
Chapter
4. Hepatotxicity Due to Mitochondrial Injury
Chapter
5. Mechanisms of Cell Death and Relevance to Drug Hepatotxicity
Chapter
6. Significance of Hepatobiliary Transporters for Drug-Induced Liver Disease
Chapter
7. Immunological Mechanisms in Drug-Induced Liver Injury
Chapter
8. Mechanistic Role of Acyl Glucuronides
Chapter
9. Nonparenchymal Cells, Inflammatory Macrophages, and Hepatotxicity
Chapter
10. Role of Tissue Repair in Liver Injury
Chapter
11. Genetic Susceptibility to Drug-Induced Liver Disease
PART II: DIAGNOSIS AND MANAGEMENT
Chapter
12. Clinicapathological Patterns of Drug-Induced Liver Disease
Chapter
13. Histopathology of Drug-Induced Liver Disease
Chapter
14. Risk Factors for Drug-Induced Liver Disease
Chapter
15. Genomics, Proteomics, and Metabolomics in the Diagnosis and Mechanisms of Drug-Induced L
Chapter
16. Causality Assessment
Chapter
17. Management of the Patient with Drug-Induced Liver Disease
PART III: HEPATOTOXICITY OF SPECIFIC DRUGS
Chapter
18. Mechanisms of Acetaminophen-Induced Liver Disease
Chapter
19. Acetaminophen: Pathology and Clinical Presentation of Hepatotoxicity
Chapter
20. Mechanisms Underlying the Hepatotoxicity of Nonsteroidal Anti-inflammatory Drugs
Chapter
21. Nonsteroidal Anti-inflammatory Drugs and Leukotriene Receptor Antagonists: Pathology and
Chapter
22. Mechanism, Pathology, and Clinical Presentation of Hepatotoxicity of Anesthetic Agents
Chapter
23. Anticonvulsant Agents
Chapter
24. Hepatotoxicity of Psychotropic Drugs and Drugs of Abuse
Chapter
25. Antibacterial and Antifungal Agents
Chapter
26. Hepatotoxicity of Antituberculosis Drugs
Chapter
27. Hepatic Toxicity of Antiviral Agents
Chapter
28. Hepatotoxicity of Cardiovascular and Antidiabetic Medications
Chapter
29. Cancer Chemotherapy
Chapter
30. Hepatotoxicity of Immunomodulating Agents and the Transplant Situation
Chapter
31. Methotrexate Controversies
Chapter
32. Adverse Effects of Hormones and Hormone Antagonists on the Liver
Chapter
33. Mushroom Poisoning: A Clinical Model of Toxin-Induced Centrilobular Necrosis
Chapter
34. Hepatotoxicity of Herbal Medicines, Vitamins, and Natural Hepatotxins
Chapter
35. Occupational and Environmental Hepatotxicity
PART IV: REGULATORY PERSPECTIVES
Chapter
36. Regulatory Perspectives
Back cover
Â
Reviews
No Review Found